Patents by Inventor Mads Axelsen

Mads Axelsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating diabetes mellitus
    Patent number: 9884094
    Abstract: A combination comprising at least a first insulin-like compound and a second insulin-like compound for treating a condition or a disease in a subject in need thereof where administration of insulin would be of benefit to said subject is described.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: February 6, 2018
    Assignee: Novo Nordisk A/S
    Inventors: Thue Johansen, Henriette Mersebach, Mads Axelsen, Martin Lange
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20150126439
    Abstract: A combination comprising at least a first insulin-like compound and a second insulin-like compound for treating a condition or a disease in a subject in need thereof where administration of insulin would be of benefit to said subject is described.
    Type: Application
    Filed: May 1, 2013
    Publication date: May 7, 2015
    Inventors: Thue Johansen, Henriette Mersebach, Mads Axelsen, Martin Lange
  • Minimising body weight gain in insulin treatment
    Patent number: 8003605
    Abstract: A method for minimizing weight gain, preventing weight gain or inducing weight loss in a mammal, said method involving a treatment regimen which comprises administration of an insulin derivative having a substituent containing from 6 to 40 carbon atoms attached to one of its amino acid residues.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: August 23, 2011
    Assignee: Novo Nordisk A/S
    Inventors: Thomas Bayer, Signe Rikke Permild, legal representative, Birgitte Sogaard, Mads Axelsen
  • Use of Factor VIIa or Factor VIIa equivalents for treating late complications of trauma
    Publication number: 20100062983
    Abstract: The invention relates to the use of Factor VIIa or a Factor VIIa equivalent for the manufacture of a medicament for preventing late complications in trauma patients.
    Type: Application
    Filed: November 13, 2009
    Publication date: March 11, 2010
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Mads Axelsen, Elisabeth Erhardtsen, Brett E. Skolnick
  • Use of Factor VIIa or Factor VIIa Equivalents for Treating Trauma
    Publication number: 20090018082
    Abstract: The invention relates to the use of Factor VIIa or a Factor VIIa equivalent for the manufacture of a medicament for treatment of trauma.
    Type: Application
    Filed: September 19, 2008
    Publication date: January 15, 2009
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Mads Axelsen, Elisabeth Erhardtsen, Brett E. Skolnick
  • Use of factor VIIa or factor VIIa equivalents for treating trauma
    Publication number: 20070078087
    Abstract: The invention relates to the use of Factor VIIa or a Factor VIIa equivalent for the manufacture of a medicament for treatment of trauma.
    Type: Application
    Filed: August 2, 2006
    Publication date: April 5, 2007
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Mads Axelsen, Elisabeth Erhardtsen, Brett Skolnick
  • Uses of factor VIIa or factor VIIa equivalents for treating late complications of trauma
    Publication number: 20070078086
    Abstract: The invention relates to the use of Factor VIIa or a Factor VIIa equivalent for the manufacture of a medicament for preventing late complications in trauma patients.
    Type: Application
    Filed: August 1, 2006
    Publication date: April 5, 2007
    Applicant: Novo Nordisk HealthCare A/G
    Inventors: Mads Axelsen, Elisabeth Erhardtsen, Brett Skolnick
  • Minimising body gain in insulin treatment
    Publication number: 20030224973
    Abstract: A method for minimising weight gain, preventing weight gain or inducing weight loss in a mammal, said method involving a treatment regimen which comprises administration of an insulin derivative having a substituent containing from 6 to 40 carbon atoms attached to one of its amino acid residues.
    Type: Application
    Filed: March 12, 2003
    Publication date: December 4, 2003
    Inventors: Thomas Bayer, Birgitte Sogaard, Mads Axelsen